| Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912) |
|---|
| 07/18/2013 | WO2013105895A1 A pharmaceutical composition comprising stable, amorphous hybrid nanopraticles of at least one protein kinase inhibitor and at least one polymeric stabilizing and matrix-forming component |
| 07/18/2013 | WO2013105894A1 A method for producing stable, amorphous hybrid nanoparticles comprising at least one protein kinase inhibitor and at least one polymeric stabilizing and matrix- forming component. |
| 07/18/2013 | WO2013105852A1 Glutamine enriched nutritional composition for preterm infants |
| 07/18/2013 | WO2013105851A1 Glutamine enriched nutritional composition for preterm infants |
| 07/18/2013 | WO2013105819A1 Stable pharmaceutical composition comprising eperisone or a pharmaceutically acceptable salt thereof and an acidifying agent |
| 07/18/2013 | WO2013105753A1 Substituted piperidine derivatives and methods for preparing the same |
| 07/18/2013 | WO2013105676A1 Benzimidazole derivatives as mch receptor antagonists |
| 07/18/2013 | WO2013105608A1 P2x4 receptor antagonist |
| 07/18/2013 | WO2013105417A1 Biochemical evaluation method |
| 07/18/2013 | WO2013105092A1 Fixed dose combination therapy of parkinson's disease |
| 07/18/2013 | WO2013105088A1 Combination therapy for the treatment of cancer |
| 07/18/2013 | WO2013105066A1 Salts of an ip receptor agonist |
| 07/18/2013 | WO2013105065A1 Fused piperidines as ip receptor agonists for the treatment of pah and related disorders |
| 07/18/2013 | WO2013105063A1 Fused piperidines as ip receptor agonists for the treatment of pulmonary arterial hypertension (pah) and related disorders |
| 07/18/2013 | WO2013105061A1 Fused dihydropyrido [2,3 -b] pyrazines as ip receptor agonists for the treatment of pulmonary arterial hypertension (pah) and related disorders |
| 07/18/2013 | WO2013105058A1 7,8- dihydropyrido [3, 4 - b] pyrazines as ip receptor agonists for the treatment of pulmonary arterial hypertension (pah) and related disorders |
| 07/18/2013 | WO2013105057A1 Fused pyrroles as ip receptor agonists for the treatment of pulmonary arterial hypertension (pah) and related disorders |
| 07/18/2013 | WO2013105056A1 Pyrrolidine- substituted flavone derivatives for prevention or treatment of oral mucositis |
| 07/18/2013 | WO2013105053A1 Compounds having antibacterial activity, process for their preparation and pharmaceutical compositions comprising them |
| 07/18/2013 | WO2013105048A2 New use of zerumbone and compositions comprising zerumbone |
| 07/18/2013 | WO2013105037A1 Inhibitors of p53-mdm2 interaction |
| 07/18/2013 | WO2013105022A2 Organic compositions to treat beta-catenin-related diseases |
| 07/18/2013 | WO2013104933A1 3,3-diphenyl-n-(1-phenylethyl) propan-1 -amine : as a new selective ligand of the sigma-1 receptors, with anti-apoptotic (cytoprotective) properties and prototypical anticancer activity |
| 07/18/2013 | WO2013104897A1 Therapeutic boron-containing compounds |
| 07/18/2013 | WO2013104892A1 Application of high dose compounds via inhalation |
| 07/18/2013 | WO2013104871A1 Composition containing agmatine, and uses thereof in preparing drugs or neutraceutical substances |
| 07/18/2013 | WO2013104831A1 Arylamide derivatives having antiandrogenic properties |
| 07/18/2013 | WO2013104830A1 Novel heteroarylamide derivatives having antiandrogenic properties |
| 07/18/2013 | WO2013104829A1 Novel arylamide derivatives having antiandrogenic properties |
| 07/18/2013 | WO2013104740A1 Organic emulsion comprising dha and epa |
| 07/18/2013 | WO2013104703A1 Substituted annulated pyrimidines and triazines, and use thereof |
| 07/18/2013 | WO2013104698A1 Scarring reducing wound treatment |
| 07/18/2013 | WO2013104613A1 Macrocyclic amides as protease inhibitors |
| 07/18/2013 | WO2013104611A1 Substituted pyrazolopyrimidines as akt kinase inhibitors |
| 07/18/2013 | WO2013104610A1 Substituted imidazopyrazines as akt kinase inhibitors |
| 07/18/2013 | WO2013104598A2 Substituted, annulated imidazoles and pyrazoles, and use thereof |
| 07/18/2013 | WO2013104597A1 Substituted triazine derivatives and use thereof as stimulators of soluble guanylate cyclase |
| 07/18/2013 | WO2013104591A1 Heterocyclic derivatives as trace amine associated receptors (taars) |
| 07/18/2013 | WO2013104577A1 Benzimidazolyl-acetamide derivatives useful as potassium channel modulators |
| 07/18/2013 | WO2013104575A1 Thienopyrimidine compounds |
| 07/18/2013 | WO2013104573A1 Pyridazine amide compounds and their use as syk inhibitors |
| 07/18/2013 | WO2013104540A1 New c5a binding nucleic acids |
| 07/18/2013 | WO2013104539A1 Nucleic acids specifically binding cgrp |
| 07/18/2013 | WO2013104399A1 Topical pharmaceutical compositions comprising bexarotene and a corticosteroids |
| 07/18/2013 | WO2013104342A1 Crystalline forms of azilsartan medoxomil potassium and preparation and uses thereof |
| 07/18/2013 | WO2013104318A1 Crystal form of prostaglandin analogue, and preparation method and use thereof |
| 07/18/2013 | WO2013104317A1 Crystal form of prostaglandin analogue, and preparation method and use thereof |
| 07/18/2013 | WO2013104263A1 Synthesis of polyhydroxy benzopyran ketone compound and anti-tumor effect thereof |
| 07/18/2013 | WO2013104257A1 Polycyclic derivatives, preparation method and medical uses thereof |
| 07/18/2013 | WO2013104067A1 Reducible self-assembled micelle drug delivery systems |
| 07/18/2013 | WO2013104050A2 Method for treating breast cancer |
| 07/18/2013 | WO2013071400A8 Apocynin-lipoic acid conjugates and uses thereof cross-reference to related applications |
| 07/18/2013 | WO2013071068A3 Treatment of hematologic malignancies with an anti-cxcr4 antibody |
| 07/18/2013 | WO2013070852A3 Compounds and compositions used to epigenetically transform cells and methods related thereto |
| 07/18/2013 | WO2013070117A3 Fluorine-containing 5-[2-(pyrid-3-yl)-ethyl]-2,3,4-tetrahydro-1н-pyrido[4,3-b]indoles as agents for reducing uncontrolled protein aggregation |
| 07/18/2013 | WO2013070116A3 Novel antithrombotic and antiatherosclerotic agent and method for producing same (variants) |
| 07/18/2013 | WO2013066442A3 Mammalian genes and gene products involved in infection |
| 07/18/2013 | WO2013066440A9 Treatment of breast cancer |
| 07/18/2013 | WO2013064900A8 Oral immediate release formulations for substituted quinazolinones |
| 07/18/2013 | WO2013061091A3 Cystic fibrosis treatment |
| 07/18/2013 | WO2013056048A3 Nutritional products comprising beta-alanine |
| 07/18/2013 | WO2013049279A3 Nitrogen mustard derivatives |
| 07/18/2013 | WO2013048949A3 Selective nr2b antagonists |
| 07/18/2013 | WO2013037943A8 Compositions and methods for treating cancer using pi3k beta inhibitor and mapk pathway inhibitor, including mek and raf inhibitors |
| 07/18/2013 | WO2013025918A3 Methods useful in the prevention of hypoxic injury |
| 07/18/2013 | WO2013021105A3 Novel derivatives of furanones and pharmaceutical composition containing same |
| 07/18/2013 | WO2013020074A3 A broadly neutralizing human antibody that recognizes the receptor-binding pocket of influenza hemagglutinin |
| 07/18/2013 | WO2012083397A8 Guanabenz-containing compound for the treatment of primary cutaneous amyloidosis |
| 07/18/2013 | WO2012076684A8 Dosages of arylsulfonamide derivatives |
| 07/18/2013 | WO2012074869A8 Benzoxazepines as inhibitors of pi3k/mtor and methods of their use and manufacture |
| 07/18/2013 | WO2012068366A9 Bifunctional molecules with antibody-recruiting and entry inhibitory activity against the human immunodeficiency virus |
| 07/18/2013 | WO2012018534A3 Substituted biphenylene compounds and methods of use thereof for the treatment of viral diseases |
| 07/18/2013 | WO2011160024A3 Compounds useful as antiviral agents, compositions, and methods of use |
| 07/18/2013 | US20130184355 Anti-Obesity and Anti-Dyslipidemic Effects of Oil Palm Phenolics in Preventing Atherosclerosis and Cardiovascular Disease |
| 07/18/2013 | US20130184352 Method of treating gaucher disease |
| 07/18/2013 | US20130184351 Lidocaine patch and methods of use thereof |
| 07/18/2013 | US20130184350 Novel NIDDM Regimen |
| 07/18/2013 | US20130184349 Method for increasing performance of offspring |
| 07/18/2013 | US20130184346 Oil and fat composition |
| 07/18/2013 | US20130184345 Oligo-benzamide compounds for use in treating cancers |
| 07/18/2013 | US20130184344 Levodopa prodrug mesylate hydrate |
| 07/18/2013 | US20130184340 Anti-cancer compositions and methods |
| 07/18/2013 | US20130184339 Anti-cancer compositions and methods |
| 07/18/2013 | US20130184337 Sodium ascorbate stimulation of elastogenesis |
| 07/18/2013 | US20130184333 Growth factor isoform |
| 07/18/2013 | US20130184331 Treatment of neurodegenerative diseases by targeting mirna |
| 07/18/2013 | US20130184330 Compositions and methods for inducing cancer cell death |
| 07/18/2013 | US20130184329 Compositions and methods for inhibiting expression of mutant egfr gene |
| 07/18/2013 | US20130184328 Ligand-conjugated monomers |
| 07/18/2013 | US20130184325 Treatment of hepatocyte growth factor (hgf) related diseases by inhibition of natural antisense transcript to hgf |
| 07/18/2013 | US20130184323 Treatment of endoplasmic reticulum stress-related diseases and conditions |
| 07/18/2013 | US20130184316 Methods for diagnosing and treating concussive disorders |
| 07/18/2013 | US20130184313 Nicotinic acetylcholine receptor ligands and the uses thereof |
| 07/18/2013 | US20130184311 Crystalline forms of the sodium salt of (4--cyclohexyl)-acetic acid |
| 07/18/2013 | US20130184310 Treatment of lupus arthritis using laquinimod |
| 07/18/2013 | US20130184308 ACTIVATED BLOOD COAGULATION FACTOR X (FXa) INHIBITOR |
| 07/18/2013 | US20130184302 Methods for treating irritable bowel syndrome (ibs) and infections |
| 07/18/2013 | US20130184297 Quinazoline derivatives substituted by aniline, preparation method and use thereof |
| 07/18/2013 | US20130184296 Parenteral solutions containing metolazone |
| 07/18/2013 | US20130184295 Method of identifying therapies for pulmonary hypertension |